# Pharmaceutical Sector â€“ Equity Research

This section covers equity research and fundamental analysis of
pharmaceutical companies, focusing on business quality, growth drivers,
regulatory aspects, and long-term value creation.

---

## ğŸ” What We Cover in the Pharma Sector

- Domestic formulations & branded generics
- API (Active Pharmaceutical Ingredients) manufacturers
- Export-oriented pharma companies
- USFDA / regulatory approvals and observations
- Product pipeline and R&D strength
- Margin sustainability and cost structures

---

## ğŸ“Š Key Analysis Areas

- Revenue growth and segment-wise performance
- Operating margins and profitability trends
- R&D expenditure and pipeline visibility
- Regulatory risk assessment
- Cash flows and balance sheet strength
- Valuation using DCF and relative metrics

---

## ğŸ“„ Research Reports

*(Company-specific pharma research reports will be added here.)*

---

âš ï¸ **Educational purpose only. Not investment advice.**
